Daniel Markowitz
Stock Analyst at Evercore ISI Group
(4.48)
# 296
Out of 5,115 analysts
22
Total ratings
76.47%
Success rate
15.72%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Downgrades: In-Line | $68 → $62 | $64.09 | -3.26% | 3 | Jan 5, 2026 | |
| GH Guardant Health | Downgrades: In-Line | $90 → $105 | $114.04 | -7.93% | 3 | Jan 5, 2026 | |
| PODD Insulet | Initiates: Outperform | $370 | $255.81 | +44.64% | 1 | Dec 16, 2025 | |
| DXCM DexCom | Initiates: In-Line | $68 | $73.04 | -6.90% | 1 | Nov 25, 2025 | |
| NTRA Natera | Maintains: Outperform | $190 → $250 | $231.14 | +8.16% | 2 | Nov 7, 2025 | |
| RMBS Rambus | Maintains: Outperform | $114 → $126 | $113.83 | +10.69% | 2 | Oct 28, 2025 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $350 → $390 | $231.12 | +68.74% | 3 | Oct 23, 2025 | |
| RGEN Repligen | Maintains: Outperform | $155 → $175 | $149.37 | +17.16% | 4 | Oct 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $75.78 | +64.95% | 2 | Oct 7, 2025 | |
| TMDX TransMedics Group | Initiates: Outperform | $155 | $133.98 | +15.69% | 1 | Sep 16, 2025 |
Bio-Techne
Jan 5, 2026
Downgrades: In-Line
Price Target: $68 → $62
Current: $64.09
Upside: -3.26%
Guardant Health
Jan 5, 2026
Downgrades: In-Line
Price Target: $90 → $105
Current: $114.04
Upside: -7.93%
Insulet
Dec 16, 2025
Initiates: Outperform
Price Target: $370
Current: $255.81
Upside: +44.64%
DexCom
Nov 25, 2025
Initiates: In-Line
Price Target: $68
Current: $73.04
Upside: -6.90%
Natera
Nov 7, 2025
Maintains: Outperform
Price Target: $190 → $250
Current: $231.14
Upside: +8.16%
Rambus
Oct 28, 2025
Maintains: Outperform
Price Target: $114 → $126
Current: $113.83
Upside: +10.69%
West Pharmaceutical Services
Oct 23, 2025
Maintains: Outperform
Price Target: $350 → $390
Current: $231.12
Upside: +68.74%
Repligen
Oct 7, 2025
Maintains: Outperform
Price Target: $155 → $175
Current: $149.37
Upside: +17.16%
Inspire Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $75.78
Upside: +64.95%
TransMedics Group
Sep 16, 2025
Initiates: Outperform
Price Target: $155
Current: $133.98
Upside: +15.69%